Cargando…

Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I

The seven human APOBEC3 enzymes (APOBEC3A through H, excluding E) are host restriction factors. Most of the APOBEC3 enzymes can restrict HIV-1 replication with different efficiencies. The HIV-1 Vif protein combats APOBEC3-mediated restriction by inducing ubiquitination and degradation in the proteas...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousefi, Maria, Annan Sudarsan, Arun Kumar, Gaba, Amit, Chelico, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960753/
https://www.ncbi.nlm.nih.gov/pubmed/36851677
http://dx.doi.org/10.3390/v15020463
_version_ 1784895586341748736
author Yousefi, Maria
Annan Sudarsan, Arun Kumar
Gaba, Amit
Chelico, Linda
author_facet Yousefi, Maria
Annan Sudarsan, Arun Kumar
Gaba, Amit
Chelico, Linda
author_sort Yousefi, Maria
collection PubMed
description The seven human APOBEC3 enzymes (APOBEC3A through H, excluding E) are host restriction factors. Most of the APOBEC3 enzymes can restrict HIV-1 replication with different efficiencies. The HIV-1 Vif protein combats APOBEC3-mediated restriction by inducing ubiquitination and degradation in the proteasome. APOBEC3F and APOBEC3G can hetero-oligomerize, which increases their restriction capacity and resistance to Vif. Here we determined if APOBEC3C, APOBEC3F, or APOBEC3G could hetero-oligomerize with APOBEC3H haplotype I. APOBEC3H haplotype I has a short half-life in cells due to ubiquitination and degradation by host proteins, but is also resistant to Vif. We hypothesized that hetero-oligomerization with APOBEC3H haplotype I may result in less Vif-mediated degradation of the interacting APOBEC3 and stabilize APOBEC3H haplotype I, resulting in more efficient HIV-1 restriction. Although we found that all three APOBEC3s could interact with APOBEC3H haplotype I, only APOBEC3F affected APOBEC3H haplotype I by surprisingly accelerating its proteasomal degradation. However, this increased APOBEC3F levels in cells and virions in the absence or presence of Vif and enabled APOBEC3F-mediated restriction of HIV-1 in the presence of Vif. Altogether, the data suggest that APOBEC3 enzymes can co-regulate each other at the protein level and that they cooperate to ensure HIV-1 inactivation rather than evolution.
format Online
Article
Text
id pubmed-9960753
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99607532023-02-26 Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I Yousefi, Maria Annan Sudarsan, Arun Kumar Gaba, Amit Chelico, Linda Viruses Article The seven human APOBEC3 enzymes (APOBEC3A through H, excluding E) are host restriction factors. Most of the APOBEC3 enzymes can restrict HIV-1 replication with different efficiencies. The HIV-1 Vif protein combats APOBEC3-mediated restriction by inducing ubiquitination and degradation in the proteasome. APOBEC3F and APOBEC3G can hetero-oligomerize, which increases their restriction capacity and resistance to Vif. Here we determined if APOBEC3C, APOBEC3F, or APOBEC3G could hetero-oligomerize with APOBEC3H haplotype I. APOBEC3H haplotype I has a short half-life in cells due to ubiquitination and degradation by host proteins, but is also resistant to Vif. We hypothesized that hetero-oligomerization with APOBEC3H haplotype I may result in less Vif-mediated degradation of the interacting APOBEC3 and stabilize APOBEC3H haplotype I, resulting in more efficient HIV-1 restriction. Although we found that all three APOBEC3s could interact with APOBEC3H haplotype I, only APOBEC3F affected APOBEC3H haplotype I by surprisingly accelerating its proteasomal degradation. However, this increased APOBEC3F levels in cells and virions in the absence or presence of Vif and enabled APOBEC3F-mediated restriction of HIV-1 in the presence of Vif. Altogether, the data suggest that APOBEC3 enzymes can co-regulate each other at the protein level and that they cooperate to ensure HIV-1 inactivation rather than evolution. MDPI 2023-02-07 /pmc/articles/PMC9960753/ /pubmed/36851677 http://dx.doi.org/10.3390/v15020463 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yousefi, Maria
Annan Sudarsan, Arun Kumar
Gaba, Amit
Chelico, Linda
Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I
title Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I
title_full Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I
title_fullStr Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I
title_full_unstemmed Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I
title_short Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I
title_sort stability of apobec3f in the presence of the apobec3 antagonist hiv-1 vif increases at the expense of co-expressed apobec3h haplotype i
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960753/
https://www.ncbi.nlm.nih.gov/pubmed/36851677
http://dx.doi.org/10.3390/v15020463
work_keys_str_mv AT yousefimaria stabilityofapobec3finthepresenceoftheapobec3antagonisthiv1vifincreasesattheexpenseofcoexpressedapobec3hhaplotypei
AT annansudarsanarunkumar stabilityofapobec3finthepresenceoftheapobec3antagonisthiv1vifincreasesattheexpenseofcoexpressedapobec3hhaplotypei
AT gabaamit stabilityofapobec3finthepresenceoftheapobec3antagonisthiv1vifincreasesattheexpenseofcoexpressedapobec3hhaplotypei
AT chelicolinda stabilityofapobec3finthepresenceoftheapobec3antagonisthiv1vifincreasesattheexpenseofcoexpressedapobec3hhaplotypei